In light of hypoxia-inducible factor-1α (HIF-1α’s) significant contributions in tumor microenvironment, in solid cancers like HNSCC, targeting and correcting hypoxia may be crucial to enhancing therapeutic response. The gene discussed is HIF1A; the disease is neoplasm.